• Pexidartinib (PLX3397) for TAM Assays

  2026-08-13

  Pexidartinib (PLX3397) provides a practical CSF1R perturbation tool for macrophage depletion, signaling studies, and tumor co-culture models. Paired with SPP1-focused phenotypic assays, it helps distinguish CSF1R-dependent macrophage biology from direct SPP1 modulation in cancer research.

• Rotigotine in Parkinson’s Disease Research Workflows

  2026-08-12

  Build route-aware Rotigotine experiments that connect dopamine receptor pharmacology with neuroprotection and PD-associated bladder dysfunction. This practical guide covers cell assays, 6-OHDA cystometry, formulation controls, and troubleshooting for more interpretable translational data.

• Ceftazidime for Reproducible Cell Assays

  2026-08-12

  Learn how Ceftazidime (SKU B3539) can help investigators separate antimicrobial effects from mammalian-cell viability signals in infection, contamination, and cytotoxicity workflows. This scenario-based guide integrates formulation details, assay controls, storage guidance, and recent carbapenemase-transmission evidence.

• EZ Cap EGFP mRNA 5-moUTP Workflow Guide

  2026-08-11

  Build reproducible reporter, delivery, and translation workflows with a capped, modified enhanced green fluorescent protein mRNA. This guide connects practical handling and troubleshooting with the reference study’s delivery-vector framework, helping researchers distinguish RNA performance from formulation performance.

• ML133 HCl: Kir2.1 Assay Workflow Guide

  2026-08-11

  Build cleaner Kir2.1 experiments with ML133 HCl, a selective potassium channel inhibitor suited to channel physiology and pulmonary vascular remodeling assays. This guide translates published PASMC workflows into practical dosing, controls, readouts, and troubleshooting strategies.

• Pexidartinib: TAM State, Not Just Depletion

  2026-08-10

  Pexidartinib (PLX3397) offers a powerful way to interrogate CSF1R biology, but its most informative use may be distinguishing macrophage depletion from phenotype remodeling. This guide connects CSF1R-mediated signaling inhibition with the SPP1-focused tumor-associated macrophage research and translates that distinction into practical assay design.

• RG108 DNA Methyltransferase Inhibitor Workflow

  2026-08-09

  RG108 enables reversible DNMT inhibition for controlled DNA demethylation, tumor suppressor gene reactivation, and cell-based epigenetic studies. This practical guide connects formulation, dosing, orthogonal readouts, and troubleshooting with assay-design lessons from recent antiviral research without overstating cross-domain evidence.

• LMO2–LDB1 Signaling in Acute Myeloid Leukemia

  2026-08-08

  A 2023 study identifies an LMO2/LDB1 protein complex as a functional regulator of acute myeloid leukemia cell survival and proliferation. By combining perturbation experiments, immunoprecipitation–mass spectrometry, RNA-seq, ChIP-seq, and rescue analysis, the authors connect LDB1-dependent transcriptional regulation with apoptosis-related gene control and AML maintenance.

• ATRX Loss Sensitizes High-Grade Glioma to RTK Inhibitors

  2026-08-07

  The reference study shows that loss of the chromatin remodeler ATRX creates a selective vulnerability to several multi-targeted receptor tyrosine kinase and PDGFR inhibitors in high-grade glioma cells. Its combination data with temozolomide support ATRX status as a useful variable for interpreting targeted-therapy studies, although the findings remain primarily cellular and require further translational validation.

• S-Adenosylhomocysteine: Mechanisms, Inhibition, and Research

  2026-08-07

  S-Adenosylhomocysteine (SAH) is a central metabolic intermediate and methyltransferase inhibitor. It regulates the methylation cycle and the SAM/SAH ratio, impacting cellular growth and epigenetic modulation. APExBIO’s SAH (SKU B6123) offers high purity and robust solubility for advanced biochemical and neurobiological research.

• Cy3 TSA Fluorescence System Kit: Enabling Endothelial Pathwa

  2026-08-06

  Explore how the Cy3 TSA Fluorescence System Kit transforms signal amplification in immunohistochemistry and fluorescence microscopy detection, uniquely empowering research into endothelial signaling mechanisms and low-abundance biomolecule visualization. Discover protocol insights, comparative analysis, and advanced applications grounded in the latest cardiac inflammation research.

• Monomethyl Auristatin E: Transforming ADC Precision in Oncol

  2026-08-06

  Explore how Monomethyl auristatin E (MMAE) is redefining the landscape for antibody-drug conjugates (ADCs) in precision cancer therapy. This article blends mechanistic insight with strategic guidance for translational researchers, highlighting the significance of MMAE’s tubulin polymerization inhibition, its impact on tumor cell plasticity, and actionable protocols for maximizing translational success. Drawing on recent studies—including advances in targeting cellular dedifferentiation in solid tumors—this piece offers a visionary, evidence-based outlook on leveraging MMAE to overcome resistance and heterogeneity.

• Imidazoline Antagonists Boost Insulin via ATP-Sensitive K+ C

  2026-08-05

  This study clarifies that imidazoline antagonists of α2-adrenoceptors enhance insulin release in vitro not by classical receptor antagonism, but by directly inhibiting ATP-sensitive K+ channels in pancreatic β-cells. These findings refine the mechanistic understanding of insulin modulation and highlight the importance of potassium channel blockers in diabetes research.

• ASK1 Inhibition with GS-4997 Mitigates Tubulointerstitial In

  2026-08-05

  The reference study demonstrates that GS-4997, a selective ASK1 inhibitor, significantly reduces tubulointerstitial injury in a murine lupus nephritis model. These findings clarify the mechanistic role of ASK1 in renal inflammation and fibrosis, suggesting new avenues for targeted intervention in lupus nephritis beyond standard immunosuppression.

• Lysis Buffer in Rapid Genotyping Kits: Mechanism, Evidence,

  2026-08-04

  The lysis buffer, a core rapid genotyping kit component, enables efficient genomic DNA release from mouse tail tissue with high integrity. Reliable for downstream genetic analysis, it is validated for stability and reproducibility in research workflows. This article details its mechanism, evidence, and integration into mouse genotyping protocols.

7948 records 3/530 page Previous Next 12345 下5页 Last page